Sosei Heptares Acquires Idorsia's Pharmaceuticals Business
Transaction adds complementary late-stage clinical development capability with profitable and fast-growing commercial operations in JapanLean, go-to-market...
Stay updated with breaking news from Sosei Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Transaction adds complementary late-stage clinical development capability with profitable and fast-growing commercial operations in JapanLean, go-to-market...
The report is a monthly listing of the top 10 most shorted securities in the Americas, EMEA and APAC regions in the large-, mid-, and small-cap exchanges.
Sosei Group Co. (OTCMKTS:SOLTF – Free Report) saw a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 1,513,300 shares, a drop of 31.3% from the May 31st total of 2,204,300 shares. Based on an average daily trading volume, of 1,000 shares, the days-to-cover ratio […]
HTL'149 has been designed as a once-daily oral treatment to address positive and negative symptoms and cognitive impairment in schizophrenia patients without the adverse effects typically associated with existing
Jefferies Financial Group downgraded shares of Sosei Group (OTCMKTS:SOLTF – Free Report) from a buy rating to an underperform rating in a research note issued to investors on Tuesday morning, The Fly reports. Sosei Group Stock Up 4.8 % Shares of OTCMKTS:SOLTF opened at $10.50 on Tuesday. The company has a 50-day simple moving average […]